The estimated Net Worth of Charles M Doucot is at least $549 Thousand dollars as of 17 August 2023. Mr. Doucot owns over 12,700 units of Psychemedics stock worth over $52,894 and over the last 7 years he sold PMD stock worth over $59,182. In addition, he makes $436,500 as Executive Vice President at Psychemedics.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Mr. Doucot PMD stock SEC Form 4 insiders trading
Charles has made over 2 trades of the Psychemedics stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 12,700 units of PMD stock worth $59,182 on 17 August 2023.
The largest trade he's ever made was selling 12,700 units of Psychemedics stock on 17 August 2023 worth over $59,182. On average, Charles trades about 1,100 units every 128 days since 2018. As of 17 August 2023 he still owns at least 23,250 units of Psychemedics stock.
You can see the complete history of Mr. Doucot stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Charles Doucot biography
Charles Doucot serves as Executive Vice President of the Company since January 2019. From May 2018 until January 2019, he served as Vice President Sales & Marketing. Prior to joining the Company, he served as Vice President Sales & GM of Burning Glass Technologies, a data analytics company, from January 2016 to December 2017. From April 2014 to January 2016 he served as Sr. VP and GM at Lumesse, an HR technology company, responsible for the Americas Business and starting a new business unit. From August 2009 to February 2014 he served as VP WW Sales and Marketing for Kalido, a big data and analytics company. Mr. Doucot began his career spending over 15 years at Hewlett-Packard Company with increasing levels of global responsibility.
What is the salary of Charles Doucot?
As the Executive Vice President of Psychemedics, the total compensation of Charles Doucot at Psychemedics is $436,500. There are 2 executives at Psychemedics getting paid more, with Raymond Kubacki having the highest compensation of $736,800.
How old is Charles Doucot?
Charles Doucot is 54, he's been the Executive Vice President of Psychemedics since 2019. There are 9 older and 1 younger executives at Psychemedics. The oldest executive at Psychemedics Corp. is Harry Connick, 94, who is the Independent Director.
What's Charles Doucot's mailing address?
Charles's mailing address filed with the SEC is C/O PSYCHEMEDICS CORPORATION, 289 GREAT ROAD, SUITE 200, ACTON, MA, 01720.
Insiders trading at Psychemedics
Over the last 21 years, insiders at Psychemedics have traded over $2,633,903 worth of Psychemedics stock and bought 95,845 units worth $742,060 . The most active insiders traders include Peter Kamin, A Clinton Allen, and Raymond C Jr Kubacki. On average, Psychemedics executives and independent directors trade stock every 101 days with the average trade being worth of $18,935. The most recent stock trade was executed by Charles M Doucot on 17 August 2023, trading 12,700 units of PMD stock currently worth $59,182.
What does Psychemedics do?
psychemedics (nasdaq: pmd) is the world's leading drug testing company using hair for the detection of drugs of abuse. psychemedics has been successfully operating for 30 years and thousands of corporations worldwide currently rely on psychemedics’ patented hair analysis technology for their pre-employment and employee drug screening. psychemedics' clients include over 10% of the fortune 500, some of the largest police departments in america, federal reserve banks, and schools. for more information, visit the psychemedics website at www.psychemedics.com.
What does Psychemedics's logo look like?
Complete history of Mr. Doucot stock trades at Psychemedics
Psychemedics executives and stock owners
Psychemedics executives and other stock owners filed with the SEC include:
-
Raymond Kubacki,
Chairman of the Board, President, Chief Executive Officer -
Raymond C. Kubacki,
Chairman, CEO & Pres -
Charles Doucot,
Executive Vice President -
Michael Schaffer,
Vice President - Laboratory Operations -
Charles M. Doucot IV,
Exec. VP -
Dr. Michael I. Schaffer Ph.D.,
VP of Laboratory Operations -
A. Clinton Allen,
Independent Director -
Fred Weinert,
Independent Director -
Walter Tomenson,
Independent Director -
Harry Connick,
Independent Director -
Patrick J. Kinney Jr.,
Sec. -
Sarah Ashby,
VP & Gen. Counsel -
Andrew Limbek,
VP of Fin. & Controller -
Annette Baumgartner,
Founder -
Dr. Werner A. Baumgartner Ph.D.,
Founder -
Peter Kamin,
Director -
Neil Lerner,
VP - Finance -
James V. Dyke,
Vice President - Sales -
Michael Weisenhoff,
-
Raymond J Ruddy,
Vice President/Controller -
Jonathan D Compton,
Vice President - Marketing -
William R Thistle,
Sr. VP and Gen. Counsel -
Peter C Monson,
VP, Treas., CFO & Asst. Sec. -
Jennifer Chmieleski,
Vice President, Controller -
Richard T Christoph,
10% owner -
William Dausey,
Vice President of Sales -
Robyn C Davis,
Director -
Andrew Reynolds,
Director -
Shannon Shoemaker,
Chief Revenue Officer -
Darius G Nevin,
Director -
Brian Hullinger,
President & CEO -
Daniella Mehalik,
Vice President - Finance